Overview
Clinical research related to infectious complications of solid organ and bone marrow transplantation, with a particular interest in the treatment and rapid diagnosis of fungal disease. Training the next generation of Transplant Infectious Disease Physicians is a special focus of mine as the Principal Investigator of our Interdisciplinary T32 Training Program funded the NIH.
Current Appointments & Affiliations
Professor of Medicine
·
2014 - Present
Medicine, Infectious Diseases,
Medicine
Professor of Pathology
·
2014 - Present
Pathology,
Clinical Science Departments
Recent Publications
Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States.
Journal Article Clin Infect Dis · February 4, 2026 BACKGROUND: Data on the epidemiology of healthcare facility-associated (HCFA) nontuberculous mycobacteria (NTM) are sparse. We performed a multicenter longitudinal cohort study of HCFA NTM epidemiology. METHODS: We retrospectively analyzed positive culture ... Full text Link to item CiteConcurrent Administration of Triazoles with Chemotherapeutic and/or Immunosuppressant Agents Known to Have Moderate-to-Severe Drug-Drug Interactions in Patients with Hematologic Malignancies Hospitalized for Invasive Aspergillosis.
Journal Article Mycopathologia · January 13, 2026 BACKGROUND: Triazoles are widely used for treatment and prevention of invasive aspergillosis (IA) but can cause serious drug-drug interactions (DDIs) with chemotherapeutic (CT) and immunosuppressant (IS) agents via CYP3A4 inhibition. The frequency of triaz ... Full text Link to item CiteCo-administration of triazoles with calcineurin or mammalian target of rapamycin inhibitors in solid organ transplant patients hospitalized with invasive aspergillosis.
Journal Article J Antimicrob Chemother · January 6, 2026 BACKGROUND: All triazoles decrease the metabolism of calcineurin inhibitors (CNIs) and mammalian target of rapamycin (mTOR) inhibitors through CYP3A4 and P-glycoprotein inhibition leading to increased exposure and the potential for serious adverse events ( ... Full text Link to item CiteRecent Grants
Novel Host-Response Biomarker Diagnostics for Invasive Aspergillosis
ResearchCo-Mentor · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029Tri-Institutional Molecular Mycology and Pathogenesis Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029UAB - Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases
ResearchPrincipal Investigator · Awarded by University of Alabama at Birmingham · 2023 - 2028View All Grants
Education, Training & Certifications
East Carolina University ·
1993
M.D.